Despite an over 86 percent gain in the stock in 2023 YTD, domestic brokerage house Investec sees pharma firm Orchid Pharma (ORCD) rising another 23 percent in the next 12 months. The brokerage has initiated coverage on the stock with a ‘buy’ call and a target price of ₹800.
Best Media Info: As high commodity inflation, geopolitical uncertainty, tepid market growth, etc. impacted the businesses of FMCG brands in the year ended March 31, 2023, various industry players have expressed high h| Marketing News
FMCG major Godrej Consumer Products Ltd on Wednesday reported a 24.47 per cent growth in its consolidated net profit to Rs 452.14 crore in the fourth quarter ended March 31, 2023, led by volume growth.
It had posted a net profit of Rs 363.24 crore in the January-March quarter a year ago, said
Mumbai: FMCG company Godrej Consumer Products Limited (GCPL) on Wednesday reported a consolidated O4FY23 net profit of Rs 452 crore, up 24.5 percent year-on-year.
Narendra Modi government softens itself to oppositions anandabazar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from anandabazar.com Daily Mail and Mail on Sunday newspapers.